Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Triamcinolone hexacetonide
Drug ID BADD_D02274
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D00985
MeSH ID C005900
PubChem ID 21826
TTD Drug ID Not Available
NDC Product Code 52128-177; 46439-8728; 59137-570
UNII I7GT1U99Y9
Synonyms triamcinolone hexacetonide | 9-fluoro-11 beta,16 alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone, 21-(3,3-dimethylbutyrate) | Aristospan
Chemical Information
Molecular Formula C30H41FO7
CAS Registry Number 5611-51-8
SMILES CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)COC(=O)CC(C)(C)C)C)O)F)C)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Fat tissue increased08.01.03.009---
Fluid retention14.05.06.002; 20.01.02.003---
Gastrointestinal perforation07.04.04.001---
Glaucoma06.03.01.002--
Glucose tolerance impaired05.06.02.001; 14.06.02.001--
Glycosuria20.02.01.005--
Headache17.14.01.001--
Hepatomegaly09.01.05.001---
Hiccups07.01.06.009; 22.12.01.001--
Hirsutism05.05.01.005; 23.02.04.001--
Hyperhidrosis08.01.03.028; 23.02.03.004--
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hypertrichosis23.02.04.002--
Hypertrophic cardiomyopathy02.04.01.002; 03.07.07.005---
Hypokalaemic syndrome14.05.03.003---
Hypopituitarism05.03.02.001--
Hypothalamo-pituitary disorder05.03.04.003---
Impaired healing08.03.02.001---
Increased appetite08.01.09.027; 14.03.01.003---
Increased insulin requirement05.06.01.006; 14.06.01.006---
Injection site infection08.02.03.019; 11.01.08.005; 12.07.03.008---
Insomnia17.15.03.002; 19.02.01.002--
Intracranial pressure increased17.07.02.002---
Intraocular pressure increased13.07.04.002---
Large intestine perforation07.04.06.005; 12.02.03.005--
Malaise08.01.01.003--
Meningitis11.01.03.001; 17.06.03.001--
Menstruation irregular05.05.01.008; 21.01.01.005--
Mood swings19.04.03.001---
The 2th Page    First    Pre   2 3 4    Next   Last    Total 4 Pages